- Upfront
- $297
- Renewal
- $297 every 11 weeks
- Advertised equivalent
- $99 per stated supply month
- Future renewals
- Checkout terms specify stopping at least 2 business days before billing
The plan requires an upfront payment
Brello Health's compounded NAD+ product page advertises $99 per month and explains that the three-month plan costs $297 upfront. The charge is a package commitment rather than three separate $99 payments. A reader comparing entry costs should therefore use $297 as the amount due, subject to the selected checkout terms.
The page describes clinical review and medication when approved. We have not purchased the plan, verified eligibility for a particular location or received a dispensed product. The listing should be understood as a pathway to a prescription assessment, not a guarantee that every person who pays will receive the same preparation or quantity.
Eleven weeks determines the next charge
The product page and checkout terms state that the NAD+ plan renews at $297 every eleven weeks. That schedule is not identical to three calendar months. Repeating the $99 monthly equivalent across a budget without accounting for renewal dates can obscure when another full payment is taken.
Ask for the initial and next billing dates, shipment schedule and quantity delivered. The product's stated supply, billing interval and pharmacy beyond-use information are separate facts. A plan covering several months should not be used to infer the stability of an opened vial or to design an administration schedule from the payment period.
Understand the two kinds of cancellation
The checkout terms allow future renewals to be stopped through the account and specify doing so at least two business days before the next billing date. Stopping another renewal does not refund an order already placed. That distinction belongs beside the cancel-anytime language when evaluating the financial commitment.
For qualifying initial cancellations after provider review, the checkout terms describe a twelve-hour request window and a $50 professional fee. The NAD+ page gives a different timing statement, so obtain confirmation of the controlling terms rather than assuming the more generous version applies. A denial of a prescription and a voluntary cancellation after review may also be treated differently.
Verify the injection and its evidence
Request the actual concentration, volume, pharmacy and included supplies before fulfillment. Confirm storage conditions, beyond-use dates and the contact for delivery concerns or clinical follow-up. The price page does not establish those details for every patient, and a shipping estimate is not a measurement of ongoing medical support.
Brello identifies this as a compounded medication, which is not FDA-approved. Its NAD+ wellness descriptions should not be treated as independently verified results from this finished injection. Discuss the purpose and relevant evidence with the clinician. The review's useful comparison facts are the $297 charge and eleven-week renewal; a sound decision still needs the actual prescription and a clear understanding of the cancellation and fulfillment conditions.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.